The Evolution Revolution
Over the past couple of years, PharmaVOICE has been reporting on the industry’s move from a pill-based model to one in which the customer, or patient, is at the center.
We’ve heard from analysts and thought leaders why this shift — driven by myriad factors, such as the changing physician landscape, a more predominant payer landscape, and technology advances that are creating incredible opportunities — is important for sustainable growth and success. And the transformation is far from over. In this month’s cover story, the business model evolution — or Re-Imagining the Future of the Life-Sciences Industry — experts discuss how the industry is set to reinvent itself into a real-world, value-based — as opposed to a volume-based — ecosystem. Innovative companies are bringing that transformation to bear by developing solutions to create a new footing in the changing world of healthcare.
As one of our thought leaders notes, the life-sciences industry has not always been able to follow innovative paradigms of other industries because of its healthcare mission, but in a marketplace increasingly driven by clinical efficacy and value-based outcomes, understanding the customer is as important for pharma companies as it is for Pepsi. This understanding of the customer is leading to holistic wellness strategies that bridge across the patient journey.
Frost & Sullivan analysts have identified what they call “Wellth is Wealth" as one of the top 15 trends for 2015. They say companies will start shifting their strategies from “profit to purpose" by creating wellness experiences through ergonomically designed environments, new wellness features in products and even health-conscious restaurants, to name a few, as individuals will increasingly look toward striking a work-life balance and demand goods and services around the wellness value proposition.
Frost & Sullivan also identified the trend of “Millennial leaders" as a top trend for the year. As the number of college graduates increases every year, they expect to see an influx of Millennial leaders in the next year. They say watch out for more horizontal leadership, collaborative working techniques, and new career paths in the coming year. In our feature article Gen Y — Gen Now, we also explore the impact that Millennials are having on the healthcare market as consumers and employees and not just in terms of sheer numbers, which is inconsiderable: 77 million, or 24% of the population.
As the newest generation of healthcare consumers and the employment pool, the Gen Y population — all 77 million of them — want us to know they want to be happy, they want to be healthy, and they want their work to mean something. And they don’t think that is too much to ask out of life. Find out what else is on the minds of this influential group in this month’s issue.
Check out the other 13 ideas and innovations that Frost & Sullivan predicts will shape our world in the coming year by going to http://ww2.frost.com.
Taren Grom
Editor
~~~~~~~~~~~~~~~~~~~~~~~~~
Their word…
Immunotherapy is a hot area of research and is expected to be a game changing approach for treating cancer.
Denise Myshko
Managing Editor
Responding to forces from consumer demand, technological advances, and data capturing innovations, the industry is set to reinvent itself from a volume- to a value-driven proposition.
Robin Robinson
Senior Editor
As Ireland emerges from an economic downturn, pharma opportunities continue to grow.
Kim Ribbink
Features Editor
- The Internet of Things
- Creative Directors — ?Secrets to Success
- 3-D Applications in Medicine
- The Wearables Craze — ?From FitBits to the iWatch
- Oncology: Patient Care
- C-Suite: EMR/HIT Companies
- Market Focus: Venezuela
- Showcase: Market Research
~~~~~~~~~~~~~~~~~~~~~~~~~
Masthead
The forum for the industry executive
Volume 15 • Number 2
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh
Managing Editor
Denise Myshko
Senior Editor
Robin Robinson
Features Editor
Kim Ribbink
Design Associate
Ariel Medel
Director of Sales
Cathy Tracy
National Account Manager
Suzanne Besse
Webcast Network Producer
Daniel Limbach
Circulation Assistant
Kathy Deiuliis
Copyright 2015
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Fifteen, Number Two
PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by -Pharma–Linx LLC, P.O.?Box 327, Titusville, NJ 08560. -Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.
Postmaster: Send address changes to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345.
PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O.?Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.
Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: [email protected].
Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: [email protected].
Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.
Advertising in PharmaVoice: To advertise in Pharma–Voice please contact our Advertising -Department at P.O.?Box 327, Titusville, NJ 08560, or -telephone us at 609.730.0196. E-mail: [email protected].
Letters …
Send your letters to [email protected]. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC. (PV)
